Analysts Set United Therapeutics Co. (NASDAQ:UTHR) Target Price at $292.80
Shares of United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) have been given a consensus rating of “Moderate Buy” by the eleven brokerages that are currently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold rating and ten have given a buy rating to the company. The average 12 month […]